Susan E Quaggin MD

Professor, Medicine, Northwestern University and Chief, Division of Nephrology/Hypertension at The Feinberg School of Medicine

Summary

I am a physcian-scientist and nephrologist in Chicago, Illinois and Chief of Nephrology/Hypertension at the Feinberg School of Medicine, Director of the Feinberg Cardiovascular and Renal Research Institute and Professor of Medicine at Northwestern University. My career focus aims to bridge discovery science and clinical medicine to implement new treatments for patients with kidney and vascular diseases. Areas of specialty include glomerular diseases, thrombotic microangiopathies and diabetic kidney disease.

Samuel Lunenfeld Res Inst., University of TorontoPost-Doctoral Fellowship, 1996 - 1997
Yale-New Haven Medical CenterFellowship, Nephrology, 1993 - 1996
St. Michael's Hospital, University of TorontoChief Residency, 1991 - 1992
University of TorontoResidency, 1988 - 1991
University of Toronto Faculty of MedicineClass of 1988

IL State Medical License 2012 - 2026
Royal College of Physicians & Surgeons of CanadaInternal Medicine
Royal College of Physicians & Surgeons of CanadaSubspecialty Certificate in Nephrology

Distinguished Scientist Award American Heart Association, 2022
President of the American Society of Nephrology American Society or Nephrology, 2021-2022
Elected to National Academy of Inventors NAI, 2021
Elected to National Academy of Medicine NAM, 2019
Study Section Chair, PBKD NIH, 2017
Elected to Council (President - 2021-2022) American Society of Nephrology, 2015
Executive Council International Society of Nephrology, 2012-2015
Elected to council International Society of Nephrology, 2010-2015
Elected to membership American Association of Physicians (AAP), 2013
Alfred Richards Newton Award International Society of Nephrology, 2013
Elected to Council American Society of Clinical Investigation, 2009-2013
Elected to membership American Society of Clinical Investigation (ASCI), 2008
Join now to see all

PubMed

TIE2 activation by antibody-clustered endogenous angiopoietin-2 prevents capillary loss and fibrosis in experimental kidney disease.
Riikka Pietilä, Amanda M Marks-Hultström, Liqun He, Sami Nanavazadeh, Susan E Quaggin
The Journal of Clinical Investigation. 2025-09-15
Glaucoma discovery on a chip.
Naoki Kiyota, Susan E Quaggin
Nature Cardiovascular Research. 2025-09-01
Enabling Organ- and Injury-Specific Nanocarrier Targeting via Surface-Functionalized PEG-b-PPS Micelles for Acute Kidney Injury.
Boaz Y Bishop, Swagat H Sharma, Ratnakar Tiwari, Simseok A Yuk, Sultan Almunif
Biorxiv. 2025-07-18

Journal Articles

Selective Permeability of Mouse Blood-Aqueous Barrier as Determined by 15N-Heavy Isotope Tracing and Mass Spectrometry
Jing Jin, Susan E Quaggin, Proceedings of the National Academy of Sciences
Angiopoietin-1 Deficiency Increases Renal Capillary Rarefaction and Tubulointerstitial Fibrosis in Mice
Susan Quaggin, MD, PLoS One

NIH Froze Funding for Clinical Trials at Northwestern University. By Fall, They’ll Run Out of FundingJune 23rd, 2025
Antimicrobial Resistance Expert to Lead Division of Infectious DiseasesJune 18th, 2025
Four Feinberg Faculty Elected to American Academy of Arts and SciencesApril 19th, 2023
Join now to see all

Northwestern University O'Brien Kidney National Resource CenterNORTHWESTERN UNIVERSITY AT CHICAGO2023–2028
Chicago Kidney Urology Hematology network FOR city-Wide reseArch tRaining and career Development (Chicago KUH FORWARD)NORTHWESTERN UNIVERSITY AT CHICAGO2021–2026
Activation of the Angiopoietin-Tie2/TEK Pathway to Treat Ocular Hypertension and GlaucomaNORTHWESTERN UNIVERSITY AT CHICAGO2016–2025